Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

British Journal of Cancer (37)
Oncogene (9)
Cell Death & Disease (6)
Cell Death and Differentiation (3)
European Journal of Human Genetics (3)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (57)
Reviews (6)
Amendments and Corrections (1)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Cell biology
Chemical biology
Diseases
Drug discovery
Genetics
Health care
Medical research
Neurology
Neuroscience
Pathogenesis
Social sciences

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–50 of 64 results

Advanced filters: Author: A Abbruzzese Clear advanced filters

Autonomic function in Holmes Adie Syndrome

M Hope-Ross
T A S Buchanan
J A Allen
Research01 Jul 1990
Eye

Volume: 4, P: 607-612
A phase I and pharmacokinetic study of intraperitoneal topotecan

L S Hofstra
A M E Bos
P H B Willemse
ResearchOpen Access27 Nov 2001
British Journal of Cancer

Volume: 85, P: 1627-1633
Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines

C J A van Moorsel
H M Pinedo
G J Peters
ResearchOpen Access07 May 1999
British Journal of Cancer

Volume: 80, P: 981-990
Fibre type composition of single motor units during synapse elimination in neonatal rat soleus muscle

Wesley J. Thompson
Lee A. Sutton
Dan A. Riley
Research21 Jun 1984
Nature

Volume: 309, P: 709-711
Interferon-α induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor

M Caraglia
A Abbruzzese
P Tagliaferri
Research27 Aug 1999
Cell Death & Differentiation

Volume: 6, P: 773-780
SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours

A Khatri
B W Williams
M N Kirstein
ResearchOpen Access03 Dec 2013
British Journal of Cancer

Volume: 110, P: 304-312
Myotonic dystrophy (DM) protein kinase levels in congenital and adult DM patients

Monica A Narang
James D Waring
Robert G Korneluk
Research24 Jul 2000
European Journal of Human Genetics

Volume: 8, P: 507-512
A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomas

A Rigg
D Cunningham
P Ross
Research01 Jan 1997
British Journal of Cancer

Volume: 75, P: 101-105
Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study

A López-Pousa
R Losa
J M Buesa
ResearchOpen Access23 May 2006
British Journal of Cancer

Volume: 94, P: 1797-1802
Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma

C Bengala
V Guarneri
P F Conte
ResearchOpen Access28 Jun 2005
British Journal of Cancer

Volume: 93, P: 35-40
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians

Daniele Ghezzi
Cecilia Marelli
Massimo Zeviani
Research13 Apr 2005
European Journal of Human Genetics

Volume: 13, P: 748-752
Carcinomas of an unknown primary origin—diagnosis and treatment

Carcinomas of an unknown primary origin (CUP) are histologically confirmed metastases for which a primary tumor could not be found despite an extensive diagnostic workup of the patient. The authors of this Review discuss the clinical evaluation of patients with CUP, describe how to identify specific CUP subsets, and outline treatment strategies and outcomes of patients with CUP.

Christophe Massard
Yohann Loriot
Karim Fizazi
Reviews01 Nov 2011
Nature Reviews Clinical Oncology

Volume: 8, P: 701-710
Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft model

G Rowlinson-Busza
A Maraveyas
AA Epenetos
Research01 Apr 1995
British Journal of Cancer

Volume: 71, P: 660-665
A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer

A Mercalli
V Sordi
L Piemonti
ResearchOpen Access10 Apr 2007
British Journal of Cancer

Volume: 96, P: 1358-1367
Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer

G Vitale
F Fonderico
G Lupoli
ResearchOpen Access12 Jun 2001
British Journal of Cancer

Volume: 84, P: 1586-1590
Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells

G Bocci
A Fioravanti
R Danesi
ResearchOpen Access19 Jul 2005
British Journal of Cancer

Volume: 93, P: 319-330
Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site

A Piga
R Nortilli
R Cellerino
ResearchOpen Access13 Apr 2004
British Journal of Cancer

Volume: 90, P: 1898-1904
The role of signaling pathways in the development and treatment of hepatocellular carcinoma

S Whittaker
R Marais
A X Zhu
Reviews19 Jul 2010
Oncogene

Volume: 29, P: 4989-5005
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

S Cascinu
R R Silva
G Catalano
ResearchOpen Access25 Jun 1999
British Journal of Cancer

Volume: 80, P: 1595-1598
Treatment of advanced pancreatic cancer with 5-fluorouracil, folinic acid and interferon alpha-2A: results of a phase II trial

H Bernhard
E Jäger-Arand
A Knuth
Research01 Jan 1995
British Journal of Cancer

Volume: 71, P: 102-105
Phase II study of S-1, a novel oral fluoropyrimidine derivative, in patients with metastatic colorectal carcinoma

A Ohtsu
H Baba
T Taguchi
ResearchOpen Access20 Jun 2000
British Journal of Cancer

Volume: 83, P: 141-145
Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities

D Urban
A Rao
L Mileshkin
ResearchOpen Access16 Jul 2013
British Journal of Cancer

Volume: 109, P: 1318-1324
A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumours

R T Penson
M V Seiden
J P Eder Jr
ResearchOpen Access28 Jun 2005
British Journal of Cancer

Volume: 93, P: 54-59
Chlorpromazine affects glioblastoma bioenergetics by interfering with pyruvate kinase M2

Claudia Abbruzzese
Silvia Matteoni
Marco G. Paggi
ResearchOpen Access13 Dec 2023
Cell Death & Disease

Volume: 14, P: 1-12
Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary

J Bridgewater
R van Laar
L Van'T Veer
ResearchOpen Access15 Apr 2008
British Journal of Cancer

Volume: 98, P: 1425-1430
Induction of apoptosis in human tumour xenografts after oral administration of uracil and tegafur to nude mice bearing tumours

E Oki
Y Sakaguchi
K Sugimachi
Research01 Sept 1998
British Journal of Cancer

Volume: 78, P: 625-630
Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma

S Kummar
M Fogarasi
T Ciesielski
ResearchOpen Access11 Jun 2002
British Journal of Cancer

Volume: 86, P: 1884-1887
Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors

R M Shaheen
S A Ahmad
L M Ellis
ResearchOpen Access14 Aug 2001
British Journal of Cancer

Volume: 85, P: 584-589
8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor

A Budillon
E Di Gennaro
P Tagliaferri
ResearchOpen Access12 Nov 1999
British Journal of Cancer

Volume: 81, P: 1134-1141
Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma

Y-X Hu
H Watanabe
N Sawabu
ResearchOpen Access07 May 1999
British Journal of Cancer

Volume: 80, P: 1075-1079
Phase II study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer

J Millar
P Scullin
M Eatock
ResearchOpen Access08 Nov 2005
British Journal of Cancer

Volume: 93, P: 1112-1116
Prospective randomised phase II study of gemcitabine at standard or fixed dose rate schedule in unresectable hepatocellular carcinoma

Z Guan
Y Wang
M Lehnert
ResearchOpen Access11 Nov 2003
British Journal of Cancer

Volume: 89, P: 1865-1869
Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease

Alessio Di Fonzo
Cristina Tassorelli
Vincenzo Bonifati
Research07 Dec 2005
European Journal of Human Genetics

Volume: 14, P: 322-331
A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer

P M Hoff
S Kopetz
J L Abbruzzese
ResearchOpen Access12 Aug 2008
British Journal of Cancer

Volume: 99, P: 722-726
A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma

P Correale
S Messinese
G Francini
ResearchOpen Access13 Apr 2004
British Journal of Cancer

Volume: 90, P: 1710-1714
Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer

A H Ko
J Hwang
M A Tempero
ResearchOpen Access05 Jul 2005
British Journal of Cancer

Volume: 93, P: 195-199
Potentiation of ionising radiation by targeting tumour necrosis factor alpha using a bispecific antibody in human pancreatic cancer

D Azria
C Larbouret
A Pèlegrin
ResearchOpen Access11 Nov 2003
British Journal of Cancer

Volume: 89, P: 1987-1994
A dose-finding study of raltitrexed (tomudex) with cisplatin and epirubicin in advanced gastro-oesophageal adenocarcinoma

M M Eatock
D A Anthony
T R J Evans
ResearchOpen Access23 May 2000
British Journal of Cancer

Volume: 82, P: 1925-1931
Sensitivity to CPT-11 of xenografted human colorectal cancers as a function of microsatellite instability and p53 status

R A Bras-Gonçalves
C Rosty
M-F Poupon
ResearchOpen Access20 Jan 2000
British Journal of Cancer

Volume: 82, P: 913-923
Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target

J S Wefel
A E Kayl
C A Meyers
ReviewsOpen Access06 Apr 2004
British Journal of Cancer

Volume: 90, P: 1691-1696
Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine

M J Overman
J Pozadzides
H Wang
ResearchOpen Access24 Nov 2009
British Journal of Cancer

Volume: 102, P: 144-150
Alternative therapy of earth elements increases the chondroprotective effects of chondroitin sulfate in mice

M Caraglia
S Beninati
M Costantino
ResearchOpen Access01 Oct 2005
Experimental & Molecular Medicine

Volume: 37, P: 476-481
5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer

A Sobrero
A Guglielmi
R Labianca
ResearchOpen Access17 Apr 2001
British Journal of Cancer

Volume: 84, P: 1023-1028
Erratum: Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells

C Sanges
C Scheuermann
P Arcari
Amendments and CorrectionsOpen Access31 May 2012
Cell Death & Disease

Volume: 3, P: e317
Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin

G V Kornek
A Schratter-Sehn
W Scheithauer
ResearchOpen Access10 Dec 1999
British Journal of Cancer

Volume: 82, P: 98-103
Sodium phenylacetate enhances the inhibitory effect of dextran derivative on breast cancer cell growth in vitro and in nude mice

M Di Benedetto
Y Kourbali
M Kraemer
ResearchOpen Access11 Sept 2001
British Journal of Cancer

Volume: 85, P: 917-923
Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells

C Sanges
C Scheuermann
P Arcari
ResearchOpen Access01 Mar 2012
Cell Death & Disease

Volume: 3, P: e276
Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity

F Y Feng
S Varambally
M K Nyati
Research04 Dec 2006
Oncogene

Volume: 26, P: 3431-3439
BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy

M Colombino
P Sperlongano
G Palmieri
ResearchOpen Access19 Jan 2012
Cell Death & Disease

Volume: 3, P: e259
Inhibition of constitutive NF-κB activity by IκBαM suppresses tumorigenesis

Shuichi Fujioka
Guido M Sclabas
Paul J Chiao
Research05 Mar 2003
Oncogene

Volume: 22, P: 1365-1370

Previous page
page 1
page 2
Next page

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

© 2026 Springer Nature Limited